Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor
- Name
- Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor
- Accession Number
- DBCAT005488
- Description
Not Available
- Drugs
Drug Drug Description Ibalizumab A CD4-specific antibody used to treat HIV infections. - Drugs & Drug Targets
Drug Target Type Ibalizumab T-cell surface glycoprotein CD4 target Ibalizumab C-C chemokine receptor type 5 target Ibalizumab C-X-C chemokine receptor type 4 target